Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$3.52 - $9.59 $15,843 - $43,164
-4,501 Reduced 12.5%
31,500 $118,000
Q4 2023

Feb 14, 2024

SELL
$5.97 - $10.36 $8.05 Million - $14 Million
-1,347,677 Reduced 97.4%
36,001 $353,000
Q3 2023

Nov 14, 2023

BUY
$8.23 - $13.93 $7.41 Million - $12.5 Million
900,098 Added 186.13%
1,383,678 $11.6 Million
Q2 2023

Aug 14, 2023

BUY
$9.97 - $14.05 $4.82 Million - $6.79 Million
483,580 New
483,580 $6.43 Million
Q2 2022

Aug 15, 2022

BUY
$4.02 - $10.43 $92,323 - $239,535
22,966 New
22,966 $102,000
Q3 2021

Nov 15, 2021

SELL
$24.86 - $35.02 $315,995 - $445,139
-12,711 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$22.3 - $36.02 $3.33 Million - $5.38 Million
-149,350 Reduced 92.16%
12,711 $444,000
Q1 2021

May 17, 2021

SELL
$26.38 - $51.15 $2.41 Million - $4.68 Million
-91,521 Reduced 36.09%
162,061 $5.4 Million
Q4 2020

Feb 16, 2021

BUY
$10.5 - $28.5 $2.66 Million - $7.23 Million
253,582 New
253,582 $6.58 Million
Q3 2020

Nov 16, 2020

SELL
$3.61 - $9.87 $91,387 - $249,859
-25,315 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$2.65 - $4.03 $67,084 - $102,019
25,315 New
25,315 $87,000
Q1 2020

May 15, 2020

SELL
$2.36 - $5.26 $1.85 Million - $4.13 Million
-785,846 Closed
0 $0
Q4 2019

Feb 18, 2020

SELL
$4.6 - $5.57 $2.37 Million - $2.87 Million
-516,046 Reduced 39.64%
785,846 $4.04 Million
Q3 2019

Nov 14, 2019

SELL
$4.99 - $6.16 $1.18 Million - $1.46 Million
-236,517 Reduced 15.37%
1,301,892 $6.72 Million
Q2 2019

Aug 14, 2019

BUY
$5.92 - $7.41 $5.03 Million - $6.29 Million
849,048 Added 123.16%
1,538,409 $9.31 Million
Q1 2019

May 15, 2019

BUY
$6.8 - $7.4 $4.69 Million - $5.1 Million
689,361 New
689,361 $4.98 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.